Takahiro Kumode

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The CC-chemokine receptor 4 (CCR4) is expressed in almost ATLL cells. Thus, anti-CCR4 antibodies can be used as a treatment strategy for ATLL. Mogamulizumab (MOG), which is a defucosylated anti-CCR4(More)
  • 1